Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2-metastatic breast cancer in US real-world clinical practice

DeMichele, A; Cristofanilli, M; Brufsky, A; Liu, XC; Mardekian, J; McRoy, L; Layman, RM; Emir, B; Torres, MA; Rugo, HS; Finn, RS

DeMichele, A (corresponding author), Univ Penn, Abramson Canc Ctr, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.

BREAST CANCER RESEARCH, 2021; 23 (1):

Abstract

Background Findings from randomized clinical trials may have limited generalizability to patients treated in routine clinical practice. This study exa......

Full Text Link